GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review

Li Xiaodong1, Xie Xuejun2

  • 1Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, Sichuan, China.

International Ophthalmology
|September 6, 2022
PubMed
Abstract

Insights

Pyroptosis, a programmed inflammatory cell death involving Gasdermin D (GSDMD), is linked to retinal vascular diseases. Targeting pyroptosis may offer new treatments for conditions like diabetic retinopathy.

Area of Science:

  • Molecular Biology
  • Immunology
  • Ophthalmology

Background:

  • Pyroptosis is a programmed inflammatory cell death pathway.
  • Key pathways include classical (NLRP3/caspase-1) and non-classical (caspase-4/5/11) routes.
  • Gasdermin D (GSDMD) is the common effector protein in pyroptosis.

Purpose of the Study:

  • To review the literature on pyroptosis mechanisms, particularly GSDMD-mediated pyroptosis.
  • To explore the role of pyroptosis in retinal vascular inflammatory diseases.
  • To summarize the pathogenesis and therapeutic prospects of pyroptosis in these conditions.

Main Methods:

  • Comprehensive literature search of 6 electronic databases (CNKI, Wanfang, VIP, PubMed, Cochrane, Embase) up to May 2022.
  • Keywords included 'Pyroptosis,' 'GSDMD,' 'Retinal Vascular Inflammatory Disease,' 'Diabetic retinopathy,' and 'Retinal vasculitis.'
  • Review and synthesis of findings on pyroptosis mechanisms, pathogenesis, and therapeutic potential.

Main Results:

  • Detailed analysis of GSDMD-mediated pyroptosis mechanisms.
  • Emphasis on the significant role of pyroptosis in the pathogenesis of inflammatory retinal vascular lesions.
  • Highlighting the potential therapeutic applications of targeting pyroptosis in these conditions.

Conclusions:

  • GSDMD-mediated pyroptosis is a critical inflammatory cell death pathway with bidirectional effects on immune and inflammatory diseases.
  • Pyroptosis is strongly implicated in the pathogenesis of retinal vascular inflammatory diseases.
  • Pyroptosis represents a promising therapeutic target for diabetic retinopathy and other retinal vasculitis conditions.